Literature DB >> 33926643

Glaucoma.

Jessica Minjy Kang1, Angelo P Tanna2.   

Abstract

Glaucoma is the leading cause of irreversible blindness worldwide. The global prevalence of glaucoma in people aged 40 to 80 years is estimated to be 3.5%. With the growing number and proportion of older persons in the population, it is projected that 111.8 million people will have glaucoma in 2040. Currently available treatments cannot reverse glaucomatous damage to the visual system; however, early diagnosis and treatment can prevent progression of the disease. In most cases, glaucoma is a chronic condition that requires lifelong management. This article reviews the pathophysiology, classification, clinical manifestations, diagnosis, and management of glaucoma.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angle-closure glaucoma; Glaucoma; Glaucoma treatment; Open-angle glaucoma; Secondary glaucoma

Mesh:

Year:  2021        PMID: 33926643     DOI: 10.1016/j.mcna.2021.01.004

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  20 in total

1.  Detailed 3D micro-modeling of rat aqueous drainage channels based on two-photon imaging: simulating aqueous humor through trabecular meshwork and Schlemm's canal by two-way fluid structure interaction approach.

Authors:  Jing Zhang; Xiuqing Qian; Haixia Zhang; Huanhuan Chu; Hang Xu; Zhicheng Liu
Journal:  Med Biol Eng Comput       Date:  2022-05-06       Impact factor: 2.602

Review 2.  A Review on Glaucoma Drainage Devices and its Complications.

Authors:  Sajal Gupta; Sandhya Jeria
Journal:  Cureus       Date:  2022-09-12

3.  A ZFP42/MARK2 regulatory network reduces the damage of retinal ganglion cells in glaucoma: a study based on GEO dataset and in vitro experiments.

Authors:  Yuan Yin; Shuai Wu; Lingzhi Niu; Shiwei Huang
Journal:  Apoptosis       Date:  2022-09-21       Impact factor: 5.561

4.  Advances in Excimer Laser Trabeculostomy within the Landscape of Minimally-Invasive Glaucoma Surgery.

Authors:  Anne Nguyen; Brian Simon; Rebecca Doan; Emily Chen; Ryan Lamrani; Jonathan Shakibkhou; Michael S Berlin
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

Review 5.  Spotlight on iPad Visual Field Tests Efficacy.

Authors:  Parul Ichhpujani; Hennaav Dhillon
Journal:  Clin Ophthalmol       Date:  2022-07-05

6.  Particle Swarm Optimization-Based Approach for Optic Disc Segmentation.

Authors:  Junyan Yi; Ya Ran; Gang Yang
Journal:  Entropy (Basel)       Date:  2022-06-08       Impact factor: 2.738

Review 7.  Application Progress of High-Throughput Sequencing in Ocular Diseases.

Authors:  Xuejun He; Ningzhi Zhang; Wenye Cao; Yiqiao Xing; Ning Yang
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

8.  Detection of Intraocular Hypertension during Opportunity Screening (Check-Up Medical Inspections).

Authors:  Gabriel Zeno Munteanu; Zeno Virgiliu Ioan Munteanu; George Roiu; Cristian Marius Daina; Lucia Georgeta Daina; Mihaela Cristina Coroi; Carmen Domnariu; Daniela Carmen Neculoiu; Adrian Sebastian Cotovanu; Dana Badau
Journal:  J Pers Med       Date:  2022-05-11

9.  There's Danger in the Drops: Systemic Effects of Ophthalmic Drops Used to Treat Glaucoma.

Authors:  Claire Haga; Thomas Waller; Abhimanyu S Ahuja; Bryan Farford; Nancy Dawson; Mingyuan Yin
Journal:  Cureus       Date:  2022-01-04

Review 10.  The Role of Axonal Transport in Glaucoma.

Authors:  Mariana Santana Dias; Xiaoyue Luo; Vinicius Toledo Ribas; Hilda Petrs-Silva; Jan Christoph Koch
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.